Cytokinetics, Inc. (CYTK)
61.23
-1.10
(-1.76%)
USD |
NASDAQ |
Oct 23, 16:00
61.23
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Market Cap : 8.496B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.496B |
| October 22, 2026 | 8.649B |
| October 21, 2026 | 8.723B |
| October 20, 2026 | 8.874B |
| October 19, 2026 | 8.693B |
| October 16, 2026 | 8.596B |
| October 15, 2026 | 8.870B |
| October 14, 2026 | 8.802B |
| October 13, 2026 | 8.551B |
| October 12, 2026 | 8.713B |
| October 09, 2026 | 8.730B |
| October 08, 2026 | 8.605B |
| October 07, 2026 | 8.481B |
| October 06, 2026 | 8.513B |
| October 05, 2026 | 8.700B |
| October 02, 2026 | 9.103B |
| October 01, 2026 | 9.106B |
| September 30, 2026 | 9.146B |
| September 29, 2026 | 9.108B |
| September 28, 2026 | 9.180B |
| September 25, 2026 | 8.972B |
| September 24, 2026 | 9.111B |
| September 23, 2026 | 9.132B |
| September 22, 2026 | 9.379B |
| September 21, 2026 | 9.375B |
| Date | Value |
|---|---|
| September 18, 2026 | 9.544B |
| September 17, 2026 | 9.702B |
| September 16, 2026 | 9.629B |
| September 15, 2026 | 9.618B |
| September 14, 2026 | 10.05B |
| September 11, 2026 | 10.24B |
| September 10, 2026 | 10.22B |
| September 09, 2026 | 10.28B |
| September 08, 2026 | 10.46B |
| September 04, 2026 | 10.09B |
| September 03, 2026 | 10.26B |
| September 02, 2026 | 9.981B |
| September 01, 2026 | 9.908B |
| August 31, 2026 | 9.840B |
| August 28, 2026 | 10.00B |
| August 27, 2026 | 10.81B |
| August 26, 2026 | 10.99B |
| August 25, 2026 | 10.75B |
| August 24, 2026 | 10.70B |
| August 21, 2026 | 10.66B |
| August 20, 2026 | 10.71B |
| August 19, 2026 | 10.79B |
| August 18, 2026 | 10.56B |
| August 17, 2026 | 10.53B |
| August 14, 2026 | 10.29B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 125.60B |
| BridgeBio Pharma, Inc. | 13.39B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| BioMarin Pharmaceutical, Inc. | 10.83B |
| Exelixis, Inc. | 16.06B |
Market Cap Related Metrics
| PS Ratio | 112.60 |
| PEG Ratio | -0.2066 |
| Price | 61.23 |
| Earnings Yield | -11.80% |
| PEGY Ratio | -0.2066 |